methylprednisolone acetate has been researched along with Spinal Diseases in 11 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Spinal Diseases: Diseases involving the SPINE.
Excerpt | Relevance | Reference |
---|---|---|
"Clinical trials first began in 1960 with methylprednisolone acetate (Depo-Medrol) administered intrathecally, in an attempt to treat both disk disease and multiple sclerosis." | 4.77 | Dangers from methylprednisolone acetate therapy by intraspinal injection. ( Nelson, DA, 1988) |
"Methylprednisolone acetate was injected into the L3-L4 disc, whereas methylprednisolone sodium succinate was injected into the L4-L5 disc." | 1.30 | Histologic changes in the intervertebral disc after intradiscal injections of methylprednisolone acetate in rabbits. ( Aoki, M; Iwata, H; Kato, F; Mimatsu, K, 1997) |
"Spinal epidural lipomatosis has been reported frequently in association with chronic systemic corticosteroid therapy, but thus far only one case has been attributed to local epidural corticosteroid injections." | 1.30 | Symptomatic spinal epidural lipomatosis after local epidural corticosteroid injections: case report. ( Lavyne, MH; Sandberg, DI, 1999) |
"A case is reported in which chemical meningism occurred after lumbar facet joint block with methylprednisolone acetate and bupivacaine." | 1.28 | Chemical meningism after lumbar facet joint block with local anaesthetic and steroids. ( Collett, BJ; Lomax, DM; Thomson, SJ, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scuderi, GJ | 1 |
Cuellar, JM | 1 |
Cuellar, VG | 1 |
Yeomans, DC | 1 |
Carragee, EJ | 1 |
Angst, MS | 1 |
Shoham, S | 1 |
Marr, KA | 1 |
Khot, A | 1 |
Bowditch, M | 1 |
Powell, J | 1 |
Sharp, D | 1 |
Amin, N | 1 |
Brancaccio, R | 1 |
Cohen, D | 1 |
Carrera, GF | 1 |
Williams, AL | 1 |
Aoki, M | 1 |
Kato, F | 1 |
Mimatsu, K | 1 |
Iwata, H | 1 |
Sandberg, DI | 1 |
Lavyne, MH | 1 |
Rothbart, P | 1 |
Thomson, SJ | 1 |
Lomax, DM | 1 |
Collett, BJ | 1 |
Nelson, DA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Using Inflammatory Biomarkers and EMG Results to Predict Epidural Injection Response in Patients Diagnosed With Lumbar Stenosis[NCT03511053] | 11 participants (Actual) | Interventional | 2017-12-19 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Measures how pain is affecting the patients lifestyle on a scale from 0 to 10 as defined by each question. The questionnaire contains 15 questions that each range on a scale form 0 to 10. The total score of the questionnaire ranges from 0 to 150. Lower values represent a better outcome. (NCT03511053)
Timeframe: Change between baseline, 1 month and 2 months post injection
Intervention | score on a scale (Mean) | ||||
---|---|---|---|---|---|
Average at baseline | Average at 1 month | Average at 2 months | Average at 1 month change | Average at 2 month change | |
All Participants | 77.5 | 53.3 | 64.3 | 27.3 | 16.2 |
Measures how pain due to spinal stenosis is effected the patient based on quality of life/pain questions and satisfaction questions for months 1 and 2 (no scales are used) SSSQ scores are reported in percentages 0-100%, higher scores indicate worse outcomes. (NCT03511053)
Timeframe: Change between baseline, 1 month and 2 months post injection
Intervention | Percentage (Mean) | ||||
---|---|---|---|---|---|
Average at baseline | Average at 1 month | Average at 2 months | Average at 1 month change | Average at 2 month change | |
All Participants | 64.1 | 53.2 | 53.5 | 11.7 | 10.3 |
Number rating of back/leg pain from 0 to 10, 0 being no pain/discomfort, 10 being extreme pain/discomfort (NCT03511053)
Timeframe: Change between baseline, 1 month and 2 months post injection
Intervention | score on a scale (Mean) | ||||
---|---|---|---|---|---|
Average at baseline | Average at 1 month | Average at 2 months | Average 1 month change | Average 2 month change | |
All Participants | 6.2 | 5.0 | 5.0 | 0.8 | 1 |
2 reviews available for methylprednisolone acetate and Spinal Diseases
Article | Year |
---|---|
Current concepts in evaluation of the lumbar facet joints.
Topics: Arthrography; Back Pain; Cartilage, Articular; Diagnosis, Differential; Humans; Joint Diseases; Lumb | 1984 |
Dangers from methylprednisolone acetate therapy by intraspinal injection.
Topics: Demyelinating Diseases; Humans; Injections, Epidural; Injections, Spinal; Intervertebral Disc; Methy | 1988 |
1 trial available for methylprednisolone acetate and Spinal Diseases
Article | Year |
---|---|
The use of intradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial.
Topics: Chronic Disease; Disability Evaluation; Female; Humans; Injections, Intralesional; Intervertebral Di | 2004 |
8 other studies available for methylprednisolone acetate and Spinal Diseases
Article | Year |
---|---|
Spinal and paraspinal infections associated with contaminated methylprednisolone acetate injections - Michigan, 2012-2013.
Topics: Aged; Anti-Inflammatory Agents; Disease Outbreaks; Drug Contamination; Female; Humans; Injections, E | 2013 |
Epidural interferon gamma-immunoreactivity: a biomarker for lumbar nerve root irritation.
Topics: Adult; Aged; Biomarkers; Bupivacaine; Cohort Studies; Epidural Space; Female; Follow-Up Studies; Hum | 2009 |
Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Arthritis; Centers for Disease Control and Prevention, | 2013 |
Cutaneous reactions to injectable corticosteroids.
Topics: Aged; Anti-Inflammatory Agents; Bupivacaine; Diagnosis, Differential; Drug Eruptions; Female; Humans | 2006 |
Histologic changes in the intervertebral disc after intradiscal injections of methylprednisolone acetate in rabbits.
Topics: Animals; Anti-Inflammatory Agents; Calcinosis; Injections, Spinal; Intervertebral Disc; Lumbar Verte | 1997 |
Symptomatic spinal epidural lipomatosis after local epidural corticosteroid injections: case report.
Topics: Aged; Anti-Inflammatory Agents; Decompression, Surgical; Humans; Injections, Epidural; Laminectomy; | 1999 |
Unilateral headache with features of hemicrania continua and cervicogenic headache--a case report.
Topics: Adult; Anti-Inflammatory Agents; Female; Headache; Humans; Injections, Spinal; Lidocaine; Methylpred | 1992 |
Chemical meningism after lumbar facet joint block with local anaesthetic and steroids.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Dura Mater; Female; Humans; Lumbar Vertebrae; Meni | 1991 |